在社区药房进行C型肝炎查-可行性和知识转移研究:PHARMA-C
Rose Prévost1,2, Émilie Roy-St-Pierre2,3, Kamilia Idir1,2
1Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Canada.
概括
北克的社区药房可以提供快速C型肝炎病毒 (HCV) 检测. 药剂师获得了信心,支持在HCV查和消除工作中发挥更大的作用.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 需要改善对C型肝炎病毒 (HCV) 检测的准入.
- 为了提高HCV检测率,新的策略是必不可少的.
研究的目的:
- 评估北克社区药房快速HCV检测的可行性.
- 评估社区药剂师 (CP) 之间关于HCV检测的知识转移 (KT).
- 确定实施HCV临床检测的障碍和促进因素.
主要方法:
- 一项为期6个月的前性CT研究 (PHARMA-C) 涉及CP和医疗保健用户 (HU).
- 临床医生接受了关于HCV风险因素,快速抗体检测,咨询和与护理联系的培训.
- 干预前和干预后的问卷调查对CP进行了可行性和KT评估;HUs完成了满意度调查.
主要成果:
- 招募了32名CP;16名CP进行了101次HCV检测,确定了2例与护理相关的阳性病例.
- 干预后,CP报告了对HCV风险识别,患者沟通和查的信心增加.
- 77.8%的CP认为在药店进行HCV查是可行的;主要障碍包括时间限制和耻辱问题.
结论:
- 在北克,医疗保健医生的点诊HCV检测是可行的.
- 鼓励扩大药剂师对HCV查的实践范围.
- 增加药剂师的参与可以推进HCV治疗级联和消除目标.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
47
相关概念视频
Hepatic Drug Clearance: Role of Transporters
113
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
113
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
88
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
88
